A new study conducted by researchers at Queen Elizabeth Hospital Birmingham in Birmingham, Great Britain, evaluated outcomes and toxicity associated with stereotactic radiotherapy in patients with ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...

Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body ...

Metastasis-directed stereotactic radiotherapy alongside biological cancer therapy appears safe, new data show.

Michael David Chuong, MD, discusses how SBRT has become a leading option for treating patients with colorectal liver ...

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that stereotactic body radiotherapy (SBRT), a form of high-dose radiation delivered in just five sessions, after ...

Please provide your email address to receive an email when new articles are posted on . Five-fraction SBRT appeared noninferior to conventional radiotherapy. Grade 2 or higher gastrointestinal adverse ...

The American Society for Radiation Oncology (ASTRO) has issued new guidelines on the appropriate use of stereotactic radiation (SBRT) in early-stage non-small cell lung cancer (NSCLC), now the leading ...

Please provide your email address to receive an email when new articles are posted on . Men assigned SBRT reported fewer adverse effects, but longer radiation courses may offer better biochemical ...

For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before the cancer comes back. Researchers at UCLA have found that a blend of a ...

Stereotactic body radiation therapy, which uses extremely precise, intense doses of radiation, proved to be effective at controlling lung cancer that had spread to a small number of sites. Systemic ...